MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-20-0008058
Stereokem Pharmaceuticals Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹6.31 Cr
▲ 1011% YoY
Net loss · FY 2023
₹1.24 Cr
Net margin -19.7%
EBITDA · FY 2023
₹81.21 Lakh
EBITDA margin 12.9%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹13.61 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
48
Provident fund records
About Stereokem Pharmaceuticals Private Limited
Data last updated:
Stereokem Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Stereokem Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2012PTC112863. Its GSTIN is 37AARCS2002E2ZJ (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Thaduri Srivani and Venkateshwar Thaduri Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Visakhapatnam, Andhra Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹6.31 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.24 Cr (net margin -19.7%) and EBITDA of ₹81.21 Lakh (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 15% over five years.
The company has about 48 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹13.61 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
Stereokem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0008058). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stereokem.com.
Company details
CIN U24100AP2012PTC112863
Registration Number 112863
Incorporation Date 11 February 2012
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Stereokem Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0008058
CIN history
Stereokem Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100AP2012PTC112863, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100AP2012PTC112863 | Current |
| U24100TG2012PTC079103 | Previous |
| U24100AP2012PTC079103 | Previous |
Key People
Thaduri Srivani Director Venkateshwar Thaduri Kumar Director Narayana Varma Vegiraju Director Recognitions & Rankings of Stereokem Pharmaceuticals
Contact details
Stereokem Pharmaceuticals Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is stereokem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 27A22 Sy.No.14P Denotified Area – Apsez Iala – Atchutapuram Lalam Koduru (V) Ram, Billi (M), Visakhapatnam, Andhra Pradesh, India – 531061
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stereokem Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Stereokem Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Stereokem Pharmaceuticals Private Limited
FY 2024 filings availableStereokem Pharmaceuticals Private Limited reported revenue of ₹6.31 Cr (up 1011% YoY) for FY 2023.
Revenue · FY 2023
₹6.31 Cr ▲ 1011%
Net loss · FY 2023
₹1.24 Cr margin -19.7%
EBITDA · FY 2023
₹81.21 Lakh margin 12.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 25%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 103%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹6.31 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | -19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stereokem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stereokem Pharmaceuticals Private Limited
Stereokem Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thaduri Srivani | Director | 26 Dec 2012 | 13 Years 9 Months | Current |
| Venkateshwar Thaduri Kumar Also directs: Stereokem Private Limited, Jyostna Laboratories Private Limited | Director | 11 Feb 2012 | 14 Years 8 Months | Current |
| Narayana Varma Vegiraju | Director | 31 Mar 2022 | 4 Years 6 Months | Current |
Auditor
Stereokem Pharmaceuticals Private Limited is audited by B V SWAMI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B V SWAMI & CO | FY 2023 | 009151S |
Shareholding
The shareholding of Stereokem Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stereokem Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.61 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Sep 2021 | 100500360 | Hdfc Bank Limited | ₹11.29 Lakh | Open | |
| 24 Mar 2021 | 100434557 | Hdfc Bank Limited | ₹13.5 Cr | Open |
To see the full charge records of Stereokem Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Stereokem Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Stereokem Pharmaceuticals, 1 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by Novartis Ag | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh, and 1 other | Disposed |
To see the full case history of Stereokem Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stereokem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stereokem Pharmaceuticals Private Limited has a workforce of 48 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
48
Active EPFO establishments
1
Employee growth
26.32%
GST
Stereokem Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AARCS2002E2ZJ | Andhra Pradesh | Active | 09 Sep 2019 |
To see the full GST registrations and return filing status of Stereokem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stereokem Pharmaceuticals Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Narayana Varma Vegiraju was appointed as Director on 31 Mar 2022.
AGM
Stereokem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Stereokem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with Hdfc Bank Limited of Rs. 13.50 Cr registered on 24 Mar 2021 with Charge ID 100434557 was modified on 21 Jun 2023.
Appointed
Narayana Varma Vegiraju was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 100500360 was registered on 15 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.50 Cr with Charge ID 100434557 was registered on 24 Mar 2021.
Ceased
Thaduri Srivani ceased to be Additional Director.
Ceased
Janagani Satyanarayana ceased to be Director.
Appointed
Thaduri Srivani was appointed as Director.
Appointed
Venkateshwar Thaduri Kumar was appointed as Director.
Incorporation
11 Feb 2012
Stereokem Pharmaceuticals Private Limited was registered on 11 Feb 2012 with Roc Vijayawada & aged 14 years 8 months as per MCA records.
Frequently asked questions
Stereokem Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2012 (14+ years old) and is registered under CIN U24100AP2012PTC112863.
Stereokem Pharmaceuticals has 3 current directors:
- Thaduri Srivani - Director
- Venkateshwar Thaduri Kumar - Director
- Narayana Varma Vegiraju - Director
The latest financial statements of Stereokem Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stereokem Pharmaceuticals is 37AARCS2002E2ZJ, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stereokem Pharmaceuticals is U24100AP2012PTC112863. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stereokem Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Stereokem Pharmaceuticals was incorporated on 11 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Vijayawada.
Narayana Varma Vegiraju was appointed as Director on 31 Mar 2022. Thaduri Srivani ceased to be Additional Director on 10 Aug 2013. Janagani Satyanarayana ceased to be Director on 26 Dec 2012. Stereokem Pharmaceuticals has 5 board changes on record in total.
Yes, Stereokem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0008058).
Stereokem Pharmaceuticals can be reached through the website stereokem.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.